Bristol-Myers Squibb Company
DE ˙ XTRA ˙ US1101221083
47,44 € ↑0,88 (1,88%)
2026-06-03
DEL PRIS
SecurityDE:BRM / Bristol-Myers Squibb Company
InstitutionAtlantic Trust, LLC
Latest Disclosed Ownership2,423 shares
Latest Disclosed Value $ 146,940
Atlantic Trust, LLC reports 0.57% decrease in ownership of BRM / Bristol-Myers Squibb Company

On May 6, 2026 - Atlantic Trust, LLC filed a 13F-HR form disclosing ownership of 2,423 shares of Bristol-Myers Squibb Company (DE:BRM) valued at $127,014 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 9, 2026 disclosing 2,437 shares of Bristol-Myers Squibb Company. This represents a change in shares of -0.57% during the quarter. The current value of the position is $114,935 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-06 2026-03-31 13F BRISTOL-MYERS SQUIBB COM 110122108 2,423 -14 -0.57 147 11.45 0.0240
2026-02-09 2025-12-31 13F BRISTOL-MYERS SQUIBB COM 110122108 2,437 -276 -10.17 131 7.38 0.0207
2025-11-10 2025-09-30 13F BRISTOL-MYERS SQUIBB COM 110122108 2,713 -598 -18.06 122 -20.26 0.0209
2025-08-08 2025-06-30 13F BRISTOL-MYERS SQUIBB COM 110122108 3,311 593 21.82 153 -7.27 0.0290
2025-05-09 2025-03-31 13F Bristol Myers Squibb Com 110122108 2,718 -1,002 -26.94 166 -21.43 0.0369
2025-02-10 2024-12-31 13F BRISTOL-MYERS SQUIBB COM 110122108 3,720 12 0.32 210 9.95 0.0455
2024-11-13 2024-09-30 13F BRISTOL-MYERS SQUIBB COM 110122108 3,708 13 0.35 192 24.84 0.0459
2024-08-09 2024-06-30 13F BRISTOL-MYERS SQUIBB COM 110122108 3,695 14 0.38 153 -23.12 0.0382
2024-05-10 2024-03-31 13F BRISTOL-MYERS SQUIBB COM 110122108 3,681 13 0.35 200 5.85 0.0522
2024-02-06 2023-12-31 13F BRISTOL-MYERS SQUIBB COM 110122108 3,668 12 0.33 188 -11.32 0.0515
2023-11-13 2023-09-30 13F BRISTOL-MYERS SQUIBB COM 110122108 3,656 860 30.76 212 15.22 0.0698
2023-08-08 2023-06-30 13F BRISTOL-MYERS SQUIBB COM 110122108 2,796 9 0.32 184 -4.66 0.0592
2023-05-10 2023-03-31 13F Bristol Myers Squibb COM 110122108 2,787 8 0.29 193 0.0616
2023-02-01 2022-12-31 13F BRISTOL-MYERS SQUIBB COM 110122108 2,779 -494 -15.09 0 -100.00 0.0667
2022-11-14 2022-09-30 13F BRISTOL-MYERS SQUIBB COM 110122108 3,273 2,213 208.77 232 182.93 0.0807
2022-08-11 2022-06-30 13F Bristol Myers Squibb COM 110122108 1,060 0 0.00 82 6.49 0.0624
2022-05-16 2022-03-31 13F Bristol Myers Squibb COM 110122108 1,060 0 0.00 77 16.67 0.0499
2022-02-09 2021-12-31 13F Bristol Myers Squibb Com 110122108 1,060 0 0.00 66 4.76 0.0389
2021-11-02 2021-09-30 13F Bristol Myers Squibb Com 110122108 1,060 0 0.00 63 -11.27 0.0399
2021-08-12 2021-06-30 13F Bristol Myers Squibb Com 110122108 1,060 1,060 71 0.0463
2021-04-30 2021-03-31 13F Bristol Myers Squibb Com 110122108 0 -1,060 -100.00 0 -100.00
2021-02-16 2020-12-31 13F Bristol Myers Squibb Com 110122108 1,060 0 0.00 66 3.13 0.0392
2020-10-23 2020-09-30 13F Bristol Myers Squibb Com 110122108 1,060 0 0.00 64 3.23 0.0508
2020-08-17 2020-06-30 13F Bristol Myers Squibb Com 110122108 1,060 0 0.00 62 5.08 0.0522
2020-05-12 2020-03-31 13F Bristol Myers Squibb Com 110122108 1,060 0 0.00 59 -13.24 0.0534
2020-02-03 2019-12-31 13F Bristol Myers Squibb Com 110122108 1,060 0 0.00 68 25.93 0.0498
2019-11-07 2019-09-30 13F Bristol Myers Squibb Com 110122108 1,060 0 0.00 54 12.50 0.0421
2019-07-31 2019-06-30 13F Bristol Myers Squibb Com 110122108 1,060 0 0.00 48 -5.88 0.0383
2019-05-13 2019-03-31 13F Bristol Myers Squibb Com 110122108 1,060 -67 -5.94 51 -13.56 0.0426
2019-02-13 2018-12-31 13F/A-1 Bristol Myers Squibb Com 110122108 1,127 -118 -9.48 59 -23.38 0.0548
2019-02-13 2018-12-31 13F Bristol Myers Squibb Com 110122108 1,127 59
2018-11-15 2018-09-30 13F Bristol Myers Squibb COM 110122108 1,245 -411 -24.82 77 -16.30 0.0591
2018-08-20 2018-06-30 13F Bristol Myers Squibb Com 110122108 1,656 1,656 33.01 92 19.48 0.0822
2018-05-15 2018-03-31 13F Bristol Myers Squibb Com 110122108 0 -1,987 -100.00 0 -100.00
2018-02-14 2017-12-31 13F Bristol Myers Squibb Com 110122108 1,987 0 0.00 122 -3.94 0.0834
2017-11-17 2017-09-30 13F Bristol Myers Squibb Com 110122108 1,987 0 0.00 127 14.41 0.0945
2017-08-21 2017-06-30 13F Bristol Myers Squibb Com 110122108 1,987 1,987 111 0.0876
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.